Penn State Hershey Cancer Institute Research
Welcome to Penn State Hershey Cancer Institute
Intellect and discovery characterize growth at the Penn State Hershey Cancer Institute. We continue to emphasize our state-of-the-art interdisciplinary patient care, in which medical, surgical and radiation oncologists jointly determine the best therapeutic course for each patient. We also focus our attention on becoming designated by the National Cancer Institute (NCI). Among other strengths, the Cancer Institute's emphasis on rural, underserved populations is a focus of the CCSG application. Many of these efforts are conducted through the Appalachian Cancer Network by volunteers throughout Pennsylvania who provide education and screening services, as well as behavioral interventions, to reduce cancer risk. Our free-standing facility, which opened June 2009, was designed to reinforce our concept of a community of individuals devoted to providing comprehensive cancer care and finding a cure for cancer.
The Cancer Institute's four scientific programs:
- Cancer Virology and Immunology
- Mechanisms of Carcinogenesis and Chemoprevention
- Cancer Control and Population Health
- Experimental Therapeutics
The scientists in the Cancer Control and Population Health and the Mechanisms of Carcinogenesis and Chemoprevention Programs continue collaborative work on two major grants examining the role of tobacco in leading to cancer. In the Experimental Therapeutics Program, our scientists have been awarded several grants from NCI in the area of nanotechnology. These projects, developed with leading researchers at University Park, are aimed at delivering new cancer treatments to individual cancer cells. Through our network of local hospitals throughout central and northeastern Pennsylvania, the Penn State Hershey Cancer Institute brings research to patients in a growing number of communities. Click here for a list of our partners and affiliates.
We continue to expand our research programs. PSHCI now has 143 investigators from 25 academic departments in six colleges located at the Hershey and University Park campuses. Over the past five years, our NCI funding has increased by 16% with a 22% increase in the past 3 years. This is quite impressive given the funding crisis at the NIH. We are making similar strides in the area of clinical trials. In the past year, 18% of our new cancer patients were enrolled on a therapeutic or prevention trial.
Committee recommends capital budget request, learns of improvement projects
Penn State is requesting $129.2 million in capital funding from the state for fiscal year 2015-16, with a primary focus on funding major building renewal and maintenance projects.More...
Trustees approve structure for new Health enterprise
The Board of Trustees committee on Finance, Business and Capital Planning today (Sept. 18) voted to recommend the creation of Penn State Health, a new not-for-profit entity that provides a legal structure to incorporate various health care facilities and service providers into one new health enterprise. The full board will vote on the motion on Friday.More...
Hershey's Hillemeier discusses year of continued clinical growth, innovation
Penn State Milton S. Hershey Medical Center continued a trend of strong financial performance, with a fiscal year highlighted by clinical growth and innovative approaches to education, research and patient care challenges spurred by a health care industry undergoing rapid transformation.More...
Diabetes Fair to highlight therapies, educational information
Adult Diabetes Education at Penn State Hershey will host a diabetes fair from 9 a.m. to noon Nov. 1 at the University Fitness Center, rooms A, B and C for all members of the community. Faculty and staff are also welcome to attend.More...